ArticleBMC pediatrics2026
Machine learning of laboratory parameters to predict mortality risk in pediatric hemophagocytic lymphohistiocytosis: a retrospective single-center study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study aims to screen key peripheral blood laboratory indicators using machine learning algorithms to develop and validate a prediction model for the 30-day mortality risk following the diagnosis of hemophagocytic lymphohistiocytosis (HLH) in children. This seeks to provide a scientific basis for the early clinical identification of high-risk patients.
methodsA retrospective cohort study was conducted, encompassing 133 children diagnosed with HLH at the Children’s Medical Center of the Affiliated Hospital of Guangdong Medical University between January 1, 2015, and December 30, 2024. Based on the survival outcome within 30 days post-diagnosis, the primary observation endpoint was categorized into a mortality group (n = 29) and a survival group (n = 104). Baseline laboratory indicators from the day of diagnosis or within the preceding 24 h were collected. The dataset was randomly partitioned into a training set and a validation set at a 7:3 ratio. Initial screening was performed via univariate analysis, followed by principal component analysis (PCA) and variance inflation factor (VIF) assessments to eliminate redundancy and isolate key predictors. Six machine learning models, including LightGBM, XGBoost, and logistic regression, were constructed using the optimized features. Model performance was evaluated using metrics such as the area under the curve (AUC) and F1 scores. The SHapley Additive exPlanations (SHAP) method was introduced for model interpretation, culminating in the construction of a visual nomogram and an online risk calculator.
resultsFive core predictive variables were identified: procalcitonin (PCT), mean corpuscular hemoglobin (MCH), aspartate aminotransferase (AST), C-reactive protein (CRP), and activated partial thromboplastin time (APTT). Among the six evaluated models, LightGBM demonstrated optimal robustness in the feature reduction experiment (validation set AUC = 0.823). SHAP visual analysis revealed that APTT and MCH contributed most significantly to the predictive outcomes; specifically, high elevated levels of APTT, AST, PCT, and CRP, coupled with a low expression level of MCH, were indicative of a high mortality risk. The risk stratification tool derived from this model successfully and significantly distinguished between high-risk and low-risk patients in both the training and validation datasets.
conclusionsA prediction model constructed using PCA feature screening and the LightGBM algorithm can effectively utilize routine peripheral blood indicators to quantitatively assess early mortality risk in pediatric HLH. The developed online calculator demonstrates substantial clinical value for auxiliary decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.